Inventor · disambiguated record
Vivekananda M. Vrudhula
Also filed as: VRUDHULA VIVEKANANDA M
23 granted patents·3 pending applications·554 citations·filing 1988–2015
95Inventor score
Top patents by PatentIndex Score
26 records- 0197US5112954AMethod of enhancing the effect of cytotoxic agentsNEORX CORP·Filed 1988·Granted May 12, 1992·147 cites·9 claims
- 0296US5521290ATargeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages and methods for their preparationNEORX CORP·Filed 1994·Granted May 28, 1996·77 cites·17 claims
- 0392US5563250ACleavable conjugates for the delivery and release of agents in native formNEORX CORP·Filed 1994·Granted Oct 8, 1996·146 cites·3 claims
- 0487US5066789ATargeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkagesNEORX CORP·Filed 1989·Granted Nov 19, 1991·43 cites·4 claims
- 0581US5141648AMethods for isolating compounds using cleavable linker bound matricesNEORX CORP·Filed 1991·Granted Aug 25, 1992·66 cites·13 claims
- 0680US9718804B2GSK-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 1, 2017·5 cites·6 claims
- 0779US8026257B2Substituted heterocyclic ethers and their use in CNS disordersBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Sep 27, 2011·4 cites·17 claims
- 0878US7572795B2Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 11, 2009·3 cites·34 claims
- 0977US6888004B2Imidazolyl derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted May 3, 2005·7 cites·23 claims
- 1076US9708337B2Aryl amide-based kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 18, 2017·3 cites·10 claims
- 1171US6939968B2Atropisomers of 3-substituted-4-arylquinolin-2-one derivativesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Sep 6, 2005·6 cites·20 claims
- 1270US7238699B2Imidazolyl derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 3, 2007·3 cites·18 claims
- 1369US8703953B2Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 22, 2014·1 cites·8 claims
- 1467US8901305B2Aryl lactam kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 2, 2014·1 cites·11 claims
- 1567US7211669B2Imidazolyl derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 1, 2007·2 cites·6 claims
- 1665US6239146B1Neurotrophic difluoroamide agentsBRISTOL MYERS SQUIBB CO·Filed 2000·Granted May 29, 2001·2 cites·13 claims
- 1764US7932256B2(S)-4-(1-cyclopropyl-2-methoxyethyl)-6-(6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino)-5-oxo-4,5-dihydropyrazine-2-carbonitrile: a pyrazinone modulator of corticotropin-releasing factor receptor activityBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 26, 2011·0 cites·2 claims
- 1863US5017693AMethods for introducing a sulfhydryl amino or hydroxyl groups to a compoundNEORX CORP·Filed 1989·Granted May 21, 1991·27 cites·10 claims
- 1959US2009156555A1Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 2053US8969564B2Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 3, 2015·0 cites·3 claims
- 2151US8372847B2Pyrazinone modulator of corticotropin-releasing factor receptor activityBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Feb 12, 2013·0 cites·5 claims
- 2244US5549883AChemically defined polymeric carriers for release of covalently linked agentsNEORX CORP·Filed 1993·Granted Aug 27, 1996·7 cites·10 claims
- 2343US6096762ANeurotrophic difluoroamide agentsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Aug 1, 2000·4 cites·11 claims
- 2443US2016222021A1Aryl ether-base kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2543US2016333006A1Aryl lacta kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2635US10035777B2Heterocyclic kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 31, 2018·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →